Michael Retsky
Harvard TH Chan School of Public Health, USA
Biography
Michael Retsky has received his PhD in Physics from University of Chicago in 1974 and made a career change into cancer research 30 years ago. He was on Judah Folkman’s staff for 12 years. He is a long term survivor of Stage IIIc colon cancer and noted for opting not to use maximum tolerated chemotherapy was the first person to use what is now called metronomic chemotherapy. He is the Founder and on the Board of Directors of Colon Cancer Alliance. He has published more than 70 papers in physics and cancer and currently editing a book on the cancer project for Nature/Springer.